## Distinguishing Features of Azithromycin vs Erythromycin ### Structural Basis **Key Point:** Azithromycin is a 15-membered ring macrolide, whereas erythromycin is a 14-membered ring macrolide. This structural difference is the primary discriminator. ### Pharmacokinetic Consequences | Feature | Azithromycin | Erythromycin | |---------|--------------|---------------| | Ring structure | 15-membered | 14-membered | | Half-life | 40–68 hours (prolonged) | 1.5–2 hours (short) | | Intracellular accumulation | High (tissue depot effect) | Moderate | | Dosing frequency | Once daily or pulse dosing | 3–4 times daily | | Tissue penetration | Superior (lung, bone, immune cells) | Adequate but lower | ### Clinical Implications **High-Yield:** The longer half-life of azithromycin allows: - Once-daily dosing (improved compliance) - Shorter treatment courses (e.g., 3-day course for CAP) - Accumulation in macrophages and neutrophils (useful for intracellular pathogens) **Clinical Pearl:** Azithromycin's superior intracellular concentration makes it the preferred choice for infections caused by intracellular organisms (Mycoplasma, Chlamydia, Legionella) and for prophylaxis in immunocompromised patients. ### Why Azithromycin is Preferred in Modern Practice The 15-membered ring structure confers: 1. Better tissue distribution 2. Lower GI side effects (less gastric irritation than erythromycin) 3. Fewer drug interactions (weaker CYP3A4 inhibition) 4. Better tolerability in children [cite:KD Tripathi 8e Ch 47]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.